Taysha Gene Therapies, Inc..
TSHA.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Taysha Gene Therapies, Inc. is a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS). The company's pipeline includes several gene therapy programs targeting rare genetic d...Show More
Better Health for All
30
Taysha Gene Therapies develops AAV-based gene therapies for rare monogenic CNS diseases.
1
In the REVEAL Phase 1/2 clinical trial for TSHA-102, 100% of 10 patients (ages 6-21) gained or regained at least one developmental milestone.
2
No treatment-related serious adverse events or dose-limiting toxicities were reported in this trial.
3
The company's products are investigational gene therapies, not revenue-generating activities with negative health outcomes.
4
The trial design for TSHA-102 is informed by longitudinal data from the Rett Syndrome Natural History Study, which has collected data from over 1,000 participants over 15 years, and the IRSF Rett Syndrome Registry.
5
Fair Money & Economic Opportunity
0
Taysha Gene Therapies, Inc. is a gene therapy company focused on developing treatments for monogenic diseases, not a financial institution.
1
The provided articles contain no specific, concrete data points related to lending, insurance, or other financial services offered to consumers.
2
Therefore, all KPIs under the 'Fair Money & Economic Opportunity' value, which are designed to assess financial institutions, are not applicable and cannot be scored based on the available evidence.
Fair Pay & Worker Respect
20
The company's worker engagement score is 4.2 out of 5, which translates to 84%.
1
This places it in the 80-tier. Additionally, there are zero regulatory actions listed in one article
2
and no information on violations, fines, or compliance issues in another,
3
indicating zero fines or violations.
Fair Trade & Ethical Sourcing
0
No evidence available to assess Taysha Gene Therapies, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No evidence available to assess Taysha Gene Therapies, Inc. on Honest & Fair Business.
Kind to Animals
-40
Taysha Gene Therapies conducts preclinical animal testing, as evidenced by its use of mice in a study for TSHA-102 gene therapy, where 15,000-25,000 animals are used per year.
1
The provided articles do not contain specific quantitative data or policy details required to assess the company against other 'Kind to Animals' KPIs, such as the extent of alternative testing methods employed or the company's animal testing policy.
No War, No Weapons
0
No evidence available to assess Taysha Gene Therapies, Inc. on No War, No Weapons.
Planet-Friendly Business
0
No evidence available to assess Taysha Gene Therapies, Inc. on Planet-Friendly Business.
Respect for Cultures & Communities
0
No information regarding Taysha Gene Therapies, Inc. (TSHA.US) or its performance related to Respect for Cultures & Communities was found in the provided articles. The articles primarily discuss the financial results of Velan Inc.
1
and general information about clinical trials,
2
neither of which is relevant to TSHA.US or the specified ethical value.
Safe & Smart Tech
0
No evidence available to assess Taysha Gene Therapies, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No specific, measurable evidence was found in the provided articles for any of the Key Performance Indicators related to Zero Waste & Sustainable Products. The articles contained only high-level commitments regarding waste reduction and responsible disposal, which do not constitute concrete actions, outcomes, or quantitative data required for scoring against the rubric.
1